Kira Williams
Nurse Practitioner · Lubbock, TXNPI 1497467393
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 10.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,334 and has fallen 99.6% since, to $5 in 2024.
Across 58 payments — averaging $25.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TG Therapeutics, Inc.$152
- Lundbeck LLC$146
- AbbVie$141
- GRT US Holding, Inc.$125
- EMD Serono, Inc.$121
- Neurocrine Biosciences, Inc.$113
- plus $683 from 19 others
What the payments were for
- Food & beverage$1,480100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TG Therapeutics, Inc. | 3 | $152 |
| Lundbeck LLC | 6 | $146 |
| AbbVie | 7 | $141 |
| GRT US Holding, Inc. | 1 | $125 |
| EMD Serono, Inc. | 3 | $121 |
| Neurocrine Biosciences, Inc. | 4 | $113 |
| AstraZeneca | 1 | $93 |
| Lilly USA, LLC | 4 | $83 |
| Genentech USA, Inc. | 4 | $78 |
| Amylyx Pharmaceuticals, Inc. | 3 | $69 |
| SK Life Science, Inc. | 3 | $60 |
| Merz Pharmaceuticals, LLC | 3 | $55 |
| GE HealthCare | 4 | $37 |
| Biogen | 1 | $29 |
| Acorda Therapeutics, Inc | 1 | $28 |
| NS Pharma, Inc. | 1 | $23 |
| Novartis | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Tanabe Pharma America, Inc. | 1 | $15 |
| Octapharma USA, Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Insightec,inc | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,480 in reported general payments places this provider in the 80th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 19 | $344 |
| Memantine Hcl | 12 | $279 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Lubbock
- Heather SullivanLubbock$28K
- Marygrace JohnsonLubbock$15K
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Onna FeuchterSouthlake$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.